Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

NCT01320566 is registered in ClinicalTrials.gov with Aeris Therapeutics as lead sponsor.

NCT NCT01320566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01320566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
Lead sponsor
Aeris Therapeutics
Phase
Phase 2/3
Overall status
Terminated
Start date
March 31, 2011
Completion date
November 30, 2013
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease(copd), lung diseases, pulmonary emphysema